About Index Trending news
Analyze
Top 50 Pricing
Verastem

Verastem

Work at Verastem? Add yourself to this profile

Verastem

Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells.

Elsewhere

Alexa global traffic share

11 Nov 2011
$20,000,000
Venture capital (Series C)
14 Jul 2011
$32,000,000
Venture capital (Series B)
16 Nov 2010
$16,000,000
Venture capital (Series A)